Aprocitentan: a new emerging prospect in the pharmacotherapy of hypertension
<h3>Background</h3><p dir="ltr">Resistant hypertension (RH) is linked to higher risks of cardiovascular events and there remains an unmet therapeutic need driven by pathophysiologic pathways unaddressed by guideline-recommended therapy. Whilst spironolactone is considered...
Saved in:
| Main Author: | |
|---|---|
| Other Authors: | |
| Published: |
2024
|
| Subjects: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|